Registration Dossier

Administrative data

Description of key information

A study for the endpoint ‘carcinogenicity’ is not required according to REACH Annex X, 8.9.1.  It was concluded in the genetic toxicity section that the substance does not cause mutagenicity to bacterial or mammalian cells, nor was there evidence of chromosomal aberrations in vitro, so it was concluded that 3-(trimethoxysilyl)propylamine is not mutagenic. Following annex X, 8.9.1 no studies for carcinogenic effects are required for substances that are not mutagenic.

Key value for chemical safety assessment

Carcinogenicity: via oral route

Endpoint conclusion
Endpoint conclusion:
no study available

Carcinogenicity: via inhalation route

Endpoint conclusion
Endpoint conclusion:
no study available

Carcinogenicity: via dermal route

Endpoint conclusion
Endpoint conclusion:
no study available

Additional information

Justification for classification or non-classification

There is no evidence that classification for carcinogenicity is required according to Regulation (EC) No 1272/2008.